Source: Annual Congress 2001 - Inflammation, infection and exercise capacity in cystic fibrosis patients
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Efrati, A. Barak, Y. Bujanover, Y. Yahav (Ramat Gan, Israel). The epidemiology and invasive therapy of portal hypertension in cystic fibrosis. Eur Respir J 2001; 16: Suppl. 31, 865

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Pulmonary hypertension in cystic fibrosis patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Electrocardiographical characteristics of pulmonary arterial hypertension in children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Pulmonary hypertension as a predictor of survival in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 230s Year: 2003 Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Source: Eur Respir J 2007; 30: 715-721 Year: 2007 Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Source: Eur Respir J 2005; 26: 586-593 Year: 2005 Comparison of clinical characteristics and prognostic factors between combined pulmonary fibrosis and emphysema/UIP versus non-UIP Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Update on management of lung infection in cystic fibrosis Source: Virtual Congress 2020 – Updates in cystic fibrosis Year: 2020 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012 Treatment with sildenafil for pulmonary hypertension in pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Antibiotic treatment of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 188-202 Year: 2014 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2012; 39: 125-132 Year: 2012 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2011; 39: 125-132 Year: 2012 Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014